In CK7+/CK20+ tumors, CDX2 expression was observed in 22 of 24 (92%) colorectal, 21 of 28 (75%) gastric, and 2 of 7 (29%) pancreatic carcinomas. Here, KRT7 is linked to exocrine pancreatic carcinoma.